Back to GA Gotham Asset Management, LLC

VIVOVIVO

Showing 0 of 15 quarters

Position history for GAGotham Asset Management, LLC's holdings in MERIDIAN BIOSCIENCE INC

As of its Q4 2022 13F, Gotham Asset Management held 10,058 shares of VIVO (Meridian Bioscience), worth $334,026. Gotham Asset Management's 13F filings listed VIVO from Q3 2022 to Q4 2022, 2 quarterly filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used